Apollon Wealth Management, LLC Gilead Sciences, Inc. Transaction History

Apollon Wealth Management, LLC

$3.45 Billion
Q3 2024

A detailed history of Apollon Wealth Management, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Apollon Wealth Management, LLC holds 26,999 shares of GILD stock, worth $2.47 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

26,999

Previous 27,275 1.01%

Holding current value

$2.47 Million

Previous $1.87 Million 20.95%

% of portfolio

0.07%

Previous 0.06%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	SELL	$66.59 - $83.99 $18,378 - $23,181	-276 Reduced 1.01%	26,999 $2.26 Million
Q2 2024 Jul 19, 2024	SELL	$63.15 - $72.88 $360,649 - $416,217	-5,711 Reduced 17.31%	27,275 $1.87 Million
Q1 2024 May 02, 2024	SELL	$71.58 - $87.29 $146,094 - $178,158	-2,041 Reduced 5.83%	32,986 $2.42 Million
Q4 2023 Feb 06, 2024	BUY	$73.27 - $83.09 $1.35 Million - $1.53 Million	18,444 Added 111.22%	35,027 $2.84 Million
Q3 2023 Nov 14, 2023	BUY	$73.94 - $80.67 $16,118 - $17,586	218 Added 1.33%	16,583 $1.24 Million
Q2 2023 Aug 04, 2023	BUY	$76.01 - $86.7 $83,382 - $95,109	1,097 Added 7.18%	16,365 $1.26 Million
Q1 2023 May 15, 2023	BUY	$77.31 - $88.08 $151,063 - $172,108	1,954 Added 14.68%	15,268 $1.27 Million
Q4 2022 Feb 15, 2023	BUY	$62.32 - $89.47 $64,251 - $92,243	1,031 Added 8.39%	13,314 $1.14 Million
Q3 2022 Nov 08, 2022	BUY	$59.54 - $68.01 $69,185 - $79,027	1,162 Added 10.45%	12,283 $758,000
Q2 2022 Aug 11, 2022	BUY	$57.72 - $65.01 $83,463 - $94,004	1,446 Added 14.95%	11,121 $687,000
Q1 2022 May 16, 2022	SELL	$57.92 - $72.58 $1.54 Million - $1.93 Million	-26,553 Reduced 73.29%	9,675 $575,000
Q4 2021 Feb 14, 2022	BUY	$64.88 - $73.64 $1.77 Million - $2.01 Million	27,295 Added 305.55%	36,228 $1.18 Million
Q3 2021 Nov 15, 2021	BUY	$67.69 - $73.03 $295,263 - $318,556	4,362 Added 95.43%	8,933 $624,000
Q2 2021 Aug 12, 2021	BUY	$63.47 - $69.35 $12,313 - $13,453	194 Added 4.43%	4,571 $315,000
Q1 2021 May 17, 2021	BUY	$60.0 - $68.46 $262,620 - $299,649	4,377 New	4,377 $283,000
Q3 2020 Nov 03, 2020	SELL	$62.1 - $78.08 $142,954 - $179,740	-2,302 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$72.34 - $84.0 $166,526 - $193,368	2,302 New	2,302 $177,000

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $114B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Apollon Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Apollon Wealth Management, LLC with notifications on news.

Account

Apollon Wealth Management, LLC Gilead Sciences, Inc. Transaction History